08:20     TEDA BIOMEDICAL<08189> - Ann. & Resumption of Trading               

                                                                              
    The Stock Exchange of Hong Kong Limited takes no                          
    responsibility for the contents of this announcement,                     
    makes no representation as to its accuracy or                             
    completeness and expressly disclaims any liability                        
    whatsoever for any loss howsoever arising from or in                      
    reliance upon the whole or any part of the contents                       
    of this announcement.                                                     
                                                                              
    Tianjin TEDA Biomedical Engineering Company Limited                       
    (a joint stock company incorporated in the People's                       
    Republic of China with limited liability)                                 
    (Stock code: 8189)                                                        
                                                                              
    ANNOUNCEMENT ON RESUMPTION OF TRADING                                     
                                                                              
    Reference is made to the announcements of Tianjin TEDA                    
    Biomedical Engineering Company Limited (the                               
    "Company") on postponement of board of director's                         
    meeting and on annual results for 2004 dated 31st                         
    March and 15th April 2005 respectively.                                   
                                                                              
    The board of directors of the Company (the "Board")                       
    would like to announce that at the request of the                         
    Company, trading in the H Shares of the Company was                       
    suspended with effect from 9:30 a.m. on 31st March                        
    2005 pending the release of the audited consolidated                      
    financial results of the Company and its subsidiaries                     
    for the year ended 31st December 2004 (the "Audited                       
    Financial Results for 2004"). As the Audited                              
    Financial Results for 2004 have been released, the                        
    Company has applied to The Stock Exchange of Hong Kong                    
    Limited for the resumption of trading in the H Shares                     
    of the Company with effect from 9:30 a.m. on 18th April,                  
    2005 (Monday).                                                            
                                                                              
    By order of the Board                                                     
    Tianjin TEDA Biomedical Engineering Company Limited                       
    Wang Shuxin                                                               
    Chairman                                                                  
                                                                              
    Tianjin, the PRC                                                          
    15th April, 2005                                                          
                                                                              
    As at the date of this announcement, the Board                            
    comprises three executive directors, being Wang                           
    Shuxin, Xie Kehua and Zheng Dan; three non-executive                      
    directors, being Feng Enqing, Liu Zhenyu and Xie                          
    Guangbei; and three independent non-executive                             
    directors, being Xian Guoming, Xiao Zhuoji and Zhao                       
    Xiuying.                                                                  
                                                                              
    This announcement, for which the directors of Tianjin                     
    TEDA Biomedical Engineering Company Limited (the                          
    "Directors") collectively and individually accept                         
    full responsibility, includes particulars given in                        
    compliance with the Rules Governing the Listing of                        
    Securities on the Growth Enterprise Market of The                         
    Stock Exchange of Hong Kong Limited for the purpose                       
    of giving information with regard to Tianjin TEDA                         
    Biomedical Engineering Company Limited. The                               
    Directors, having made all reasonable enquiries,                          
    confirm that, to the best of their knowledge and                          
    belief: (1) the information contained in this                             
    announcement is accurate and complete in all material                     
    respects and not misleading; (2) there are no other                       
    matters the omission of which would make any statement                    
    in this announcement misleading; and (3) all opinions                     
    expressed in this announcement have been arrived at                       
    after due and careful consideration and are founded                       
    on bases and assumptions that are fair and reasonable.                    
                                                                              
    This announcement will remain on the GEM website at                       
    http://www.hkgem.com on the "Latest Company                               
    Announcements" page for at least 7 days from the day                      
    of its posting.